“Cost-Effectiveness Profile, Organizational Implications and Patient Preferences on the Use of Exogenous TSH Therapy (Thyrogen®) Vs. THW in Thyroid Residue Ablation in Italy”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 17, no. 3, Oct. 2016, https://doi.org/10.7175/fe.v17i3.1264.